Certara Inc (CERT)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $1.76B
Last updated: Nov 17, 2026 at 11:05 AM ET
Certara Inc (CERT) Earnings: Report Dates and Results
Certara (CERT) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Certara reported EPS of $0.06, above the $0.05 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CERT has an expected report date of Feb 24, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 100.0% above the $0.05 reported for the quarter ended Dec 31, 2025.
CERT Earnings Call
The latest CERT earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 25 quarters below that had an estimate, CERT beat 10, missed 11 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $94.90M, up 4.4% from $90.89M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.06 | $0.05 | N/A | +20.00% | Beat | -57.1% | 11 | 0 up, 7 down | Nov 5, 2026 | $94.90M |
| Jun 30, 2026 | $0.05 | $0.06 | N/A | -16.67% | Miss | -28.6% | 9 | 1 up, 0 down | Aug 4, 2026 | $93.27M |
| Mar 31, 2026 | $0.09 | $0.11 | $0.09 - $0.12 | -18.18% | Miss | -35.7% | 11 | 0 up, 8 down | May 11, 2026 | $106.92M |
| Dec 31, 2025 | $0.05 | $0.07 | -$0.02 - $0.12 | -28.57% | Miss | -66.7% | 12 | 0 up, 1 down | Feb 26, 2026 | $103.65M |
| Sep 30, 2025 | $0.14 | $0.11 | $0.10 - $0.12 | +27.27% | Beat | +7.7% | 10 | 1 up, 4 down | Nov 6, 2025 | $90.89M |
| Jun 30, 2025 | $0.07 | $0.10 | $0.09 - $0.12 | -30.00% | Miss | 0.0% | 10 | 0 up, 2 down | Aug 6, 2025 | $92.36M |
| Mar 31, 2025 | $0.14 | $0.11 | $0.10 - $0.12 | +27.27% | Beat | +40.0% | 10 | 3 up, 0 down | May 5, 2025 | $106.00M |
| Dec 31, 2024 | $0.15 | $0.13 | $0.12 - $0.15 | +19.62% | Beat | +66.7% | 9 | 2 up, 1 down | Feb 26, 2025 | $100.36M |
| Sep 30, 2024 | $0.13 | $0.11 | $0.10 - $0.12 | +18.18% | Beat | +18.2% | 9 | 1 up, 0 down | Nov 6, 2024 | $94.82M |
| Jun 30, 2024 | $0.07 | $0.10 | $0.10 - $0.11 | -30.00% | Miss | -41.7% | 9 | 0 up, 0 down | Aug 6, 2024 | $93.31M |
| Mar 31, 2024 | $0.10 | $0.10 | $0.08 - $0.11 | 0.00% | In line | -16.7% | 10 | 0 up, 0 down | May 7, 2024 | $96.65M |
| Dec 31, 2023 | $0.09 | $0.11 | $0.08 - $0.14 | -18.18% | Miss | -43.8% | 9 | 0 up, 0 down | Feb 29, 2024 | $88.01M |
| Sep 30, 2023 | $0.11 | $0.11 | $0.10 - $0.12 | 0.00% | In line | +10.0% | 6 | 0 up, 0 down | Nov 8, 2023 | $85.58M |
| Jun 30, 2023 | $0.12 | $0.13 | $0.12 - $0.14 | -7.69% | Miss | +33.3% | 7 | 0 up, 0 down | Aug 9, 2023 | $90.45M |
| Mar 31, 2023 | $0.12 | $0.12 | $0.11 - $0.13 | 0.00% | In line | +9.1% | 7 | 0 up, 0 down | May 8, 2023 | $90.30M |
| Dec 31, 2022 | $0.16 | $0.13 | $0.11 - $0.14 | +23.08% | Beat | +1500.0% | 6 | 0 up, 0 down | Mar 1, 2023 | $86.63M |
| Sep 30, 2022 | $0.10 | $0.12 | $0.11 - $0.13 | -16.67% | Miss | +42.9% | 6 | 0 up, 0 down | Nov 7, 2022 | $84.70M |
| Jun 30, 2022 | $0.09 | $0.11 | $0.10 - $0.12 | -18.18% | Miss | +200.0% | 6 | 0 up, 0 down | Aug 9, 2022 | $82.76M |
| Mar 31, 2022 | $0.11 | $0.11 | $0.04 - $0.12 | 0.00% | In line | +83.3% | 5 | 0 up, 0 down | May 5, 2022 | $81.55M |
| Dec 31, 2021 | $0.01 | $0.09 | $0.06 - $0.11 | -88.89% | Miss | -88.9% | 5 | 0 up, 0 down | Mar 1, 2022 | $75.35M |
| Sep 30, 2021 | $0.07 | $0.06 | $0.05 - $0.06 | +16.67% | Beat | +133.3% | 4 | N/A | Nov 9, 2021 | $73.94M |
| Jun 30, 2021 | $0.03 | $0.05 | $0.04 - $0.06 | -40.00% | Miss | N/A | 6 | N/A | Aug 5, 2021 | $70.10M |
| Mar 31, 2021 | $0.06 | $0.05 | $0.04 - $0.05 | +20.00% | Beat | N/A | 4 | N/A | May 6, 2021 | $66.72M |
| Dec 31, 2020 | $0.09 | $0.03 | $0.02 - $0.05 | +200.00% | Beat | N/A | 3 | N/A | Mar 4, 2021 | $64.64M |
| Sep 30, 2020 | $0.03 | $0.02 | N/A | +50.00% | Beat | N/A | N/A | N/A | Dec 14, 2020 | $60.32M |
| Sep 30, 2019 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2019 | $53.49M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.40, down 11.1% from the year before. It was $0.07 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.40 | -11.1% |
| Dec 31, 2024 | $0.45 | N/A |
| Dec 31, 2023 | $0.44 | N/A |
| Dec 31, 2022 | $0.46 | +170.6% |
| Dec 31, 2021 | $0.17 | +127.9% |
| Dec 31, 2020 | $0.07 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,800 words across 13 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 7,766 | 13 | |
| 2026Q2 | Jun 30, 2026 | 5,396 | 13 | |
| 2026Q1 | Mar 31, 2026 | 6,609 | 14 | |
| 2025Q4 | Dec 31, 2025 | 8,004 | 13 | |
| 2025Q3 | Sep 30, 2025 | 5,193 | 12 | |
| 2025Q2 | Jun 30, 2025 | 6,365 | 13 | |
| 2025Q1 | Mar 31, 2025 | 5,963 | 13 | |
| 2024Q4 | Dec 31, 2024 | 6,262 | 12 |
2026Q3 Earnings Call
Opening remarks
Jay Liu Investor Relations Good morning, everyone. Thank you all for participating in today's conference call. On the call from Certara, we have Jon Resnick, Chief Executive Officer, and Faiz Mohammed, Interim Chief Financial Officer. Earlier today, Certara released financial results for the quarter ending September 30, 2026. A copy of the press release is available on the company's website. Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements, and actual results may differ materially from those expressed or implied in the forward-looking statements. Please refer to slide two in the accompanying presentation titled "Third Quarter 2026 Financial Results" for additional information, which you can find on the company's investor relations website. In the remarks or responses to questions, management may mention some non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are available in the recent earnings press release on the company's website. Please refer to the reconciliation tables in the accompanying materials for additional information. This conference call contains time-sensitive information and is accurate only as of today, November 5, 2026. Certara disclaims any obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. With that, I will turn the call over to Jon.
Jon Resnick CEO Thank you, Jay. Thank you all for joining today. When I hosted my first earnings call in February, I shared with you my initial impressions of Certara: that we have an extraordinary business, one that is strategically critical to the future of drug development. On that February call, I also shared that 2026 would be about improving the ways we operate, reinvigorating growth, and setting the business up to realize its full potential. What followed was attention to a focused strategy and targeted portfolio businesses, placing customers at the center of everything we do, and a dedication to execution and operations. Over the past three quarters, we have completed the divestiture of the Regulatory and Medical Writing business, reorganized our business around how customers buy our software and services, and brought in key talent to strengthen our commercial and product leadership teams. We have also moved quickly to embed AI across our offerings and our operations, and to define a multi-pronged strategy to accelerate growth. There is more work to do, but we are executing against that plan. Turning to Q3, I am pleased to say the business is showing signs of strengthening. Revenue for the quarter was $94.9 million, up 4% year-over-year on a continuing operations basis.
Frequently Asked Questions About CERT
When is Certara's next earnings date?
Certara's next earnings report is expected for Feb 24, 2027.
Did CERT beat earnings estimates last quarter?
Yes. Certara reported EPS of $0.06 for the quarter ended Sep 30, 2026, above the $0.05 estimate, a 20.00% surprise.
What EPS do analysts expect from CERT next quarter?
The consensus EPS estimate for Certara for the quarter ending Dec 31, 2026 is $0.10 from 15 analysts, with estimates from $0.09 to $0.13.
How often does CERT beat earnings estimates?
Certara beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +0.09%.
CERT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors